Ruxolitinib With Radiation and Temozolomide Compared to Radiation and Temozolomide for Newly Diagnosed Glioblastoma

Clinical trial NCT06991101 · RECRUITING

Trial details

NCT number: NCT06991101
Sponsor: Baptist Health South Florida
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Glioblastoma Brain Cancer Glioblastoma Multiforme Glioblastoma Multiforme of Brain Glioblastoma Multiforme, Adult MGMT-Unmethylated Glioblastoma MGMT-Methylated Glioblastoma

Start date: 2025-12-03
Primary completion: 2030-12-01
Enrollment: 190

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.